Citation Impact
Citing Papers
The Dutch Deep Hyperthermia Trial: results in cervical cancer
2002
Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis
2014 StandoutNobel
Molecular mechanisms mediating metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Hypoxia‐inducible factor‐1α contributes to hypoxia‐induced chemoresistance in gastric cancer
2007
Cancer–stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis
2012 StandoutNobel
Regulation of the breast cancer stem cell phenotype by hypoxia-inducible factors
2015 StandoutNobel
Analysis of Hypoxia-Induced Metabolic Reprogramming
2014 StandoutNobel
Hypoxia-Inducible Factors in Physiology and Medicine
2012 StandoutNobel
Ras Inhibition in Glioblastoma Down-regulates Hypoxia-Inducible Factor-1α, Causing Glycolysis Shutdown and Cell Death
2005
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
2009 Standout
Nasopharyngeal carcinoma
2005 Standout
Expanding global access to radiotherapy
2015 Standout
Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation
2017 Standout
Hyperthermia in combined treatment of cancer
2002 Standout
Color-coded Doppler imaging of the vena contracta as a basis for quantification of pure mitral regurgitation
1994
HIF-1: upstream and downstream of cancer metabolism
2009 StandoutNobel
Heating the patient: a promising approach?
2002 Standout
Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up
2015
Overexpression of Intrinsic Hypoxia Markers HIF1α and CA-IX Predict for Local Recurrence in Stage T1-T2 Glottic Laryngeal Carcinoma Treated With Radiotherapy
2008
PET and Planar Imaging of Tumor Hypoxia With Labeled Metronidazole
2006
HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
2013 StandoutNobel
Head and neck cancer
2008 Standout
Malignant astrocytic glioma: genetics, biology, and paths to treatment
2007 Standout
Nasopharyngeal carcinoma
2019 Standout
Inhibitors of hypoxia-inducible factor 1 block breast cancer metastatic niche formation and lung metastasis
2012 StandoutNobel
Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: Results of the French STIC prospective study
2012
Current status of flow convergence for clinical applications: Is it a leaning tower of “PISA”?
1996
Methods of estimation of mitral valve regurgitation for the cardiac surgeon
2009
Tumor Hypoxia and Malignant Progression
2004
FIGO IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy
1999
Conformity index: A review
2006 Standout
Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter?
2004
HIF at the crossroads between ischemia and carcinogenesis
2004
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
The hypoxic tumor microenvironment: A driving force for breast cancer progression
2015 StandoutNobel
Management of T1–T2 glottic carcinomas
2004
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Clinical use of intensity-modulated radiotherapy: part II
2004
Nasopharyngeal carcinoma
2015 Standout
Adipokines: inflammation and the pleiotropic role of white adipose tissue
2004 Standout
Hypoxia in cancer: significance and impact on clinical outcome
2007 Standout
Translation of new cancer treatments from pet dogs to humans
2008 Standout
Frequency and severity of tricuspid regurgitation determined by Doppler echocardiography in primary pulmonary hypertension
2003
Clinical Outcomes of Intensity-Modulated Pelvic Radiation Therapy for Carcinoma of the Cervix
2010
Enhancing Radiotherapy by Lipid Nanocapsule-Mediated Delivery of Amphiphilic Gold Nanoparticles to Intracellular Membranes
2014
L'effet volume en radiothérapie première partie : effet volume et tumeur
2003
Cancers des voies aérodigestives supérieures : bénéfices cliniques de la radiothérapie conformationnelle et de la modulation d’intensité
2002
FDG-PET for management of cervical and ovarian cancer
2005
Imaging Assessment of Tricuspid Regurgitation Severity
2019
Hypoxia Inducible Factor 1-α Regulates of Platelet Derived Growth Factor-B in Human Glioblastoma Cells
2005
Mutation of von Hippel–Lindau Tumour Suppressor and Human Cardiopulmonary Physiology
2006 StandoutNobel
Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial
2000
Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma
2004
Cervical cancer
2003
Assessment of tricuspid regurgitation by Doppler color flow imaging: angiographic correlation
1994
A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma
2012
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
2009 Standout
Determinants of functional tricuspid regurgitation in incomplete tricuspid valve closure: Doppler color flow study of 109 patients
1994
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial
2011 Standout
Surgical results of pelvic exenteration in the treatment of gynecologic cancer
2014
Regulation of Metabolism by Hypoxia-Inducible Factor 1
2011 StandoutNobel
Image guidance for precise conformal radiotherapy
2003
Cervical cancer
2019 Standout
The standardized uptake value for F‐18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival
2007
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
2009 StandoutNobel
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
2012 StandoutNobel
Predicting Radiation Pneumonitis After Chemoradiation Therapy for Lung Cancer: An International Individual Patient Data Meta-analysis
2013
Hypoxia-inducible factor 1 mediates TAZ expression and nuclear localization to induce the breast cancer stem cell phenotype
2014 StandoutNobel
American Society of Clinical Oncology Clinical Practice Guideline for the Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer
2006
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Selective Killing of Hypoxia-Inducible Factor-1–Active Cells Improves Survival in a Mouse Model of Invasive and Metastatic Pancreatic Cancer
2009 StandoutNobel
In Vitro Flow Mapping of Regurgitant Jets
1996
HIFs and tumors—causes and consequences
2004
Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation
2011 StandoutNobel
Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and doppler echocardiography
2003 Standout
Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells
2016 StandoutNobel
Pyruvate kinase M2 regulates glucose metabolism by functioning as a coactivator for hypoxia-inducible factor 1 in cancer cells
2011 StandoutNobel
Proximal Jet Size by Doppler Color Flow Mapping Predicts Severityof Mitral Regurgitation
1995
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
T1-T2N0 Squamous Cell Carcinoma of the Glottic Larynx Treated With Radiation Therapy
2001
Oxygen Sensing, Hypoxia-Inducible Factors, and Disease Pathophysiology
2013 StandoutNobel
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
HIF-1α and TAZ serve as reciprocal co-activators in human breast cancer cells
2015 StandoutNobel
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression
2012 StandoutNobel
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
Ras inhibition in glioblastoma down-regulates hypoxia-inducible factor-1alpha, causing glycolysis shutdown and cell death.
2005
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
2014 StandoutNobel
Works of K Chao being referenced
The Clinical Implications of Hydronephrosis and the Level of Ureteral Obstruction in Stage IIIB Cervical Cancer
1998
Radiation therapy morbidity in carcinoma of the uterine cervix: dosimetric and clinical correlation
1999
Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation
2001
Applicator-guided intensity-modulated radiation therapy
2002
Comparison of intensity modulated radiation therapy (IMRT) treatment techniques for nasopharyngeal carcinoma
2001
Inhibition of hypoxia inducible factor 1α causes oxygen-independent cytotoxicity and induces p53 independent apoptosis in glioblastoma cells
2003
Management of stage II (T2N0M0) glottic carcinoma by radiotherapy and conservation surgery
1999
Chemotherapy Significantly Increases the Risk of Radiation Pneumonitis in Radiation Therapy of Advanced Lung Cancer
2010
Influence of the Coanda effect on color Doppler jet area and color encoding. In vitro studies using color Doppler flow mapping.
1992
Tumor Size, Irradiation Dose, and Long-Term Outcome of Carcinoma of Uterine Cervix
1998